Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Aldesleukin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clinigen notes results from the MIROCALS trial investigating low dose ProleukinÂ
    Clinigen notes results from the MIROCALS trial investigating low dose ProleukinÂ

    08 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/08/2569947/0/en/Clinigen-notes-results-from-the-MIROCALS-trial-investigating-low-dose-Proleukin-aldesleukin-in-patients-with-amyotrophic-lateral-sclerosis.html

    GLOBENEWSWIRE
    08 Dec 2022
    Share Share
    Cancer drug could aid heart attack recovery
    Cancer drug could aid heart attack recovery

    06 Sep 2021

    // FIRSTWORD PHARMA

    https://www.firstwordpharma.com/node/1861153

    FIRSTWORD PHARMA
    06 Sep 2021
    Share Share
    Exelixis' Growth 'Heavily' Depends on Success of Tumor Drugs Cabometyx, XL092
    Exelixis' Growth 'Heavily' Depends on Success of Tumor Drugs Cabometyx, XL092

    19 Jul 2021

    // PRESS RELEASE

    https://ir.exelixis.com/news-releases/news-release-details/exelixis-announces-clinical-trial-collaboration-and-supply-0

    PRESS RELEASE
    19 Jul 2021
    Share Share
    Synthekine Launches with $82 Million Series A Financing to Advance Pipeline
    Synthekine Launches with $82 Million Series A Financing to Advance Pipeline

    17 Sep 2020

    // BIOSPACE

    https://www.biospace.com/article/releases/synthekine-launches-with-82-million-series-a-financing-to-advance-pipeline-of-engineered-cytokine-therapeutics-optimized-for-cancer-and-autoimmune-diseases/?s=80

    BIOSPACE
    17 Sep 2020
    Share Share
    Clinigen signs agreement with Iovance Biotherapeutics
    Clinigen signs agreement with Iovance Biotherapeutics

    14 Jan 2020

    // PRESS RELEASE

    https://www.clinigengroup.com/media/2010/clinigen_iovance_final-v2.pdf

    PRESS RELEASE
    14 Jan 2020
    Share Share
    Clinigen completes acquisition of US rights to Proleukin
    Clinigen completes acquisition of US rights to Proleukin

    02 Apr 2019

    // BIOSPACE

    https://www.biospace.com/article/clinigen-completes-acquisition-of-us-rights-to-proleukin/?s=79

    BIOSPACE
    02 Apr 2019
    Share Share